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Non-pruritic linear rash in a patient with metastatic cancer
Clinical Presentation

A 27-year-old male patient presented with generalized painless, non-pruritic skin rash. He had been diagnosed
with metastatic germ cell tumor, for which he had undergone the first chemotherapy cycle consisting of cisplatin,
etoposide, and bleomycin, one week prior to presentation. He had no history of alopecia and demonstrated no
changes in the appearance of his nails, oral ulcers, or joint swelling. Moreover, he did not report any lifestyle change
or travel or recent intake of mushroom. Physical examination revealed a rash involving the trunk and extremities,
appearing as linear brown streaks with no erythema or excoriation marks (Figure 1).

Figure 1 - Multiple, brown patches in a linear configuration on A) the chest B) the back, and C) the lower limbs.
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Question
What is the most likely diagnosis?
A. Contact dermatitis
B. Dermatitis artefecta
C. Flagellate hyperpigmentation
D. Shiitake dermatitis

Answer
C. Flagellate hyperpigmentation

Discussion
Based on the clinical presentation, a diagnosis of bleomycin-induced flagellate dermatitis was made. The patient
required no treatment as he was completely asymptomatic, and the rash had started fading spontaneously. However,
it flared up during the chemotherapy cycles. Given the classic appearance of the rash, biopsy was not needed.
Bleomycin, a glycopeptide, is an anti-neoplastic antibiotic that is generally used to treat various malignancies
and to achieve chemical pleurodesis.1 The pulmonary adverse effects of bleomycin are well-established; however,
its cutaneous manifestations are somewhat uncommon and vary among patients. Flagellate hyperpigmentation
constitutes a unique cutaneous adverse effect of bleomycin, which has been reported to have an incidence of up to
10%; however, severe and widespread dissemination of the rash is rare .1 It is noteworthy that most cases of flagellate
hyperpigmentation are associated with pruritus.2 However, it may also present as completely asymptomatic, as in
our case.
Low bleomycin hydrolase levels in the skin and lungs are implicated as the basis of complications in these
tissues. Moreover, minor skin trauma (namely from scratching) results in local bleomycin accumulation by
increasing the cutaneous blood flow.1 Rash associated with shiitake dermatitis, which might be observed after
ingesting raw or undercooked shiitake mushrooms, present with similar features.3 However, in the present case, the
patient had no history of recent intake of shiitake mushrooms. Thus, this rare case of extensive non-pruritic rash
following bleomycin administration was diagnosed as bleomycin-induced flagellate dermatitis based on the clinical
characteristics.
Learning points: i) Flagellate hyperpigmentation constitutes a unique cutaneous adverse effect of bleomycin.ii)
Although most cases of flagellate hyperpigmentation are associated with pruritus, it may also present as completely
asymptomatic
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